Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Irritable Bowel Syndrome, March 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 64 articles: HTML format

Single Articles

1. BEKTAS A
   Non-celiac Gluten Sensitivity: A New Clinical Entity or Growing Controversy?
   Euroasian J Hepatogastroenterol. 2025;15:170-172.
   PubMed    
   Abstract available
   
   

2. LI Q, Fan M, Gao A, Qin L, et al
   Evaluating the real-world safety of cholestyramine for the treatment of hyperlipidemia: disproportionality analysis of FAERS data.
   Front Med (Lausanne). 2026;13:1765949.
   PubMed    
   Abstract available
   
   

3. QUAN Z, Song W, Huang Q, Wang J, et al
   The effects of different exercise interventions on clinical outcomes of irritable bowel syndrome and their potential mechanisms: a systematic review and network meta-analysis.
   Front Immunol. 2026;17:1730624.
   PubMed    
   Abstract available
   
   

4. COSIMATO I, Brescia A, Franci G, Casolaro V, et al
   Emerging Therapeutic Approaches for Modulating the Intestinal Microbiota.
   Pharmaceutics. 2026;18:197.
   PubMed    
   Abstract available
   
   

5. DE STEFANIS S, Colavita F, Maggi F, Antonioli M, et al
   SARS-CoV-2 Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis.
   Viruses. 2026;18:247.
   PubMed    
   Abstract available
   
   

6. COLECCHIA L, Marasco G, Meacci D, Cremon C, et al
   Nutritional Management of Irritable Bowel Syndrome.
   Nutrients. 2026;18:699.
   PubMed    
   Abstract available
   
   

7. INDRIO F, Di Mauro A, Perrone G, Greco A, et al
   Long-Term Efficacy of Limosilactobacillus reuteri DSM17938 in the Prevention of Functional Abdominal Pain Disorders.
   Nutrients. 2026;18:687.
   PubMed    
   Abstract available
   
   

8. SEIDITA A, Mansueto P, Pistone M, Soresi M, et al
   Atopy and Other Sensitivities in Non-Celiac Wheat Sensitivity: Is There an Associated Hypersensitivity Background? (dagger).
   Nutrients. 2026;18:609.
   PubMed    
   Abstract available
   
   

9. PAMUEANGMUN P, Kham NNN, Kanpiengjai A, Saenjum C, et al
   Probiotic Potential of Weizmannia coagulans MA42, an Endospore-Forming Probiotic Bacterium Capable of Dietary Fiber Digestion.
   Foods. 2026;15:710.
   PubMed    
   Abstract available
   
   

10. TALASILA S, Ahmed A, Malick H, Nadir U, et al
    Modestly Increased Incidence of Irritable Bowel Syndrome in Hidradenitis Suppurativa: A Retrospective Cohort Study Using TriNetX.
    Int J Dermatol. 2026 Feb 26. doi: 10.1111/ijd.70357.
    PubMed    
    
    
    

11. XIONG N, Mi Q, Sun Q, Liu Q, et al
    Disrupted Prefrontal Regulation of Social Rejection in Irritable Bowel Syndrome.
    Psychother Psychosom. 2026 Feb 26:1-26. doi: 10.1159/000551116.
    PubMed    
    Abstract available
    
    

12. ARGYRIOU K, Manolakis A, Tsakiridou E, Christodoulou D, et al
    Linaclotide for irritable bowel syndrome with constipation: integrating realworld evidence into the therapeutic puzzle.
    Acta Gastroenterol Belg. 2026;89:65-77.
    PubMed    
    Abstract available
    
    

13. MARASCO G, Meacci D, Sarnelli G, Tosetti C, et al
    Diarrhea management: from pathophysiology to microbiota modulation.
    Therap Adv Gastroenterol. 2026;19:17562848261424324.
    PubMed    
    Abstract available
    
    

14. STURKENBOOM R, Essers BAB, Masclee AAM, Keszthelyi D, et al
    Gender-dependent preferences of medical professionals in treatment choices for irritable bowel syndrome: results from an exploratory study.
    BMC Gastroenterol. 2026 Feb 25. doi: 10.1186/s12876-026-04660.
    PubMed    
    
    
    

15. MISHRA AS, Ghosh B, Malliappan SP, Dutta G, et al
    Formulation approaches for colon-specific drug delivery: conventional to nanocarrier systems.
    RSC Adv. 2026;16:10022-10059.
    PubMed    
    Abstract available
    
    

16. MI Z, Huaien BU, Dongjun W, Naijin Z, et al
    Efficacy of Tongxie Yaofang compared with pinaverium bromide on irritable bowel syndrome with liver depression and spleen deficiency: a systematic review and Meta-analysis.
    J Tradit Chin Med. 2026;46:14-21.
    PubMed    
    Abstract available
    
    

17. TANG Y, He Z, Zhang Q, Liu Y, et al
    Hippocampal Neuronal Ferroptosis Driven by Lipocalin-2 Mediates Comorbid Visceral Pain and Anxiety in Irritable Bowel Syndrome.
    Mol Neurobiol. 2026;63:469.
    PubMed    
    Abstract available
    
    

18. ZHANG HF, Huang R, Jiang F, Li F, et al
    [Clinical study of acupuncture at force-sensitive acupoints in treatment of diarrhea-predominant irritable bowel syndrome].
    Zhen Ci Yan Jiu. 2026;51:233-239.
    PubMed    
    Abstract available
    
    

19. GHOSH D, Sharma R, Katiyar D, Mittal A, et al
    An overview of commercially available polymers for colon-targeted drug delivery systems.
    J Biomater Sci Polym Ed. 2026 Feb 23:1-39. doi: 10.1080/09205063.2026.2628305.
    PubMed    
    Abstract available
    
    

20. PALENCA I, Franzin SB, Pesce M, Sarnelli G, et al
    Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging uses.
    Pharmacol Rep. 2026 Feb 23. doi: 10.1007/s43440-026-00830.
    PubMed    
    
    
    

21. ATALAY BR, Yurtseven B, Akbaba E, Ayaz F, et al
    Immunomodulatory Effects of Hyoscine Butylbromide on Mammalian Macrophages.
    Fundam Clin Pharmacol. 2026;40:e70075.
    PubMed    
    Abstract available
    
    

22. VENTURA L, Keaser ML, Hernandez-Rojas LG, Shahed M, et al
    Sex-dependent changes in insular cortex connectivity in a rat model of comorbid pain.
    bioRxiv [Preprint]. 2026 Feb 10:2026.02.07.704080.
    PubMed    
    Abstract available
    
    

23. ASHAOLU TJ, Suttikhana I
    Probiotic therapeutics: A critical review of mechanisms, clinical efficacy, and the frontier of precision microbiome modulation.
    Int Immunopharmacol. 2026;175:116412.
    PubMed    
    Abstract available
    
    

24. GROS M, Gros-Baneres B, Mesonero JE, Latorre E, et al
    Dietary intake as a tool to support diagnosis of irritable bowel syndrome.
    Med Clin (Barc). 2026;166:107388.
    PubMed    
    Abstract available
    
    

25. LI Z, Morgan L, Gong TM, Mula M, et al
    Bidirectional Associations Between Anxiety and Gastrointestinal Disorders: A Retrospective Cohort Study Using the TriNetX Database.
    Cureus. 2026;18:e102747.
    PubMed    
    Abstract available
    
    

26. COTTON CEM, Hopper AD, Sanders DS
    Are we missing early pancreatic dysfunction? Expanding faecal elastase testing beyond pancreatic disease.
    Curr Opin Gastroenterol. 2026 Mar 4. doi: 10.1097/MOG.0000000000001163.
    PubMed    
    Abstract available
    
    

27. WU X, Tang Y, He Z, Yang F, et al
    EXPRESS: miRNA-let7b5p Alleviates Visceral Hypersensitivity by Inhibiting the Activation of Spinal Microglial in Male IBS-like Rats.
    Mol Pain. 2026 Mar 4:17448069261430202. doi: 10.1177/17448069261430202.
    PubMed    
    Abstract available
    
    

28. LIU ZH, Liu YQ, Zhang QL, Lin C, et al
    [Spinal lncRNA_RT1-CE10 attenuates chronic visceral hypersensitivity in rats with irritable bowel syndrome via inhibiting microglial activation].
    Sheng Li Xue Bao. 2026;78:246-252.
    PubMed    
    Abstract available
    
    

29. FAN F, Cao Y, He ZQ, Yang F, et al
    Oxytocin relieves visceral hypersensitivity through GABAB1-TRPV1 in rats with irritable bowel syndrome.
    Sheng Li Xue Bao. 2026;78:173-181.
    PubMed    
    Abstract available
    
    

30. ZENG L, Zhou W
    Deciphering the mitochondria-gut microbiota axis in irritable bowel syndrome: pathogenic insights and therapeutic frontiers.
    J Transl Med. 2026 Mar 2. doi: 10.1186/s12967-026-07894.
    PubMed    
    
    
    

31. LIU S, Domingo-Vidal M, Madhu B, Binyamin D, et al
    Metabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut.
    Nat Rev Gastroenterol Hepatol. 2026 Mar 2. doi: 10.1038/s41575-026-01178.
    PubMed    
    Abstract available
    
    

32. WANG S, Zhou T, Wang X, Zhao J, et al
    Bridging the gap: Prevotella/Segatella's impact on gut barrier function and advanced cultivation strategies to realize the uses in gut health.
    Gut Microbes. 2026;18:2638001.
    PubMed    
    Abstract available
    
    

33. ALHARAZI RM, Sultan I, Alahmadi GA, Ghandour R, et al
    Association Between Stress Management Interventions and Symptom Severity in Adults With Irritable Bowel Syndrome (IBS) in Saudi Arabia.
    Cureus. 2026;18:e102466.
    PubMed    
    Abstract available
    
    

34. VIGNAL L, de Lahondes R, Gillibert A, Tavolacci MP, et al
    Metagenomic analysis of salivary microbiota in patients with anorexia nervosa and association with functional digestive disorders (ORMICAN pilot study).
    BMJ Nutr Prev Health. 2025;8:e001112.
    PubMed    
    Abstract available
    
    

35. NETO JN, Veigas KIS, Gomes LMRS, Silva LC, et al
    Prevalence and related factors of irritable bowel syndrome in women with chronic pelvic pain.
    Clinics (Sao Paulo). 2026;81:100884.
    PubMed    
    Abstract available
    
    

36. SALEH AO, Awashra A, Abouelmagd AA, Elkholy M, et al
    Vagal Nerve Stimulation for Chronic Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Neuromodulation. 2026 Feb 27:S1094-7159(26)00010.
    PubMed    
    Abstract available
    
    

37. STENMAN E, Bolmsjo BB, Nilholm C, Grundberg A, et al
    Poor self-rated health in individuals with irritable bowel syndrome but no increased 10-year cardiovascular risk: results from a Swedish population-based screening program.
    Front Cardiovasc Med. 2026;13:1702012.
    PubMed    
    Abstract available
    
    

38. KHOLWADWALA AS, Quigley EMM
    Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Are They Overdiagnosed?
    Acta Gastroenterol Latinoam. 2025;55:276-291.
    PubMed    
    Abstract available
    
    

39. ALSMADI MM
    P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modeling.
    Drug Metab Dispos. 2026;54:100254.
    PubMed    
    Abstract available
    
    

40. VAIDYULA VR, Kundu RV
    Vitiligo and Risk of Gastrointestinal Disorders in the United States: A Case-Control Study.
    Arch Dermatol Res. 2026;318:119.
    PubMed    
    
    
    

41. SHAH Q, Soldera J
    Exploring effectiveness of Metronidazole, Bismuth, and Rifaximin in treating small intestinal bacterial overgrowth and irritable bowel syndrome: A systematic review.
    World J Methodol. 2026;16:107169.
    PubMed    
    Abstract available
    
    

42. PRODAN R, Soldera J
    Mirtazapine for the treatment of irritable bowel syndrome: A systematic review.
    World J Methodol. 2026;16:107908.
    PubMed    
    Abstract available
    
    

43. HUO T, Huang X, Liao J, Zhang H, et al
    The bidirectional effects and mechanisms of the oral and gut microbiomes: a narrative review.
    Front Immunol. 2026;17:1697413.
    PubMed    
    Abstract available
    
    

44. NEWMAN-BOOTH A, Fairhurst E, Vasant DH
    Racial Disparities in the Diagnosis and Management Between Secondary Care Ethnic Minority and White British Patients With Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2026;38:e70272.
    PubMed    
    Abstract available
    
    

45. KIM YS, Park SY, Kang SJ, Lee MW, et al
    Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridium difficile Infection Considering Sex-based Differences.
    J Neurogastroenterol Motil. 2026 Mar 10. doi: 10.5056/jnm25221.
    PubMed    
    Abstract available
    
    

46. ARCHANA B, Priyathersini N, Mathangi DC
    Improvement from Irritable Bowel Syndrome and Anxiety Through Integrative Yoga, Meditation and Naturopathy: A Case Report.
    Adv Mind Body Med. 2026 Mar 11:ADV1463.
    PubMed    
    Abstract available
    
    

47. FALL AAA, Gueye MN, Diouf MN, Toure B, et al
    Functional Bowel Disorders: A Retrospective Descriptive Study in Dakar, Senegal.
    Cureus. 2026;18:e103082.
    PubMed    
    Abstract available
    
    

48. BYKOVA SV, Dbar SR, Sabelnikova EA, Belostotsky NI, et al
    [Justification for the use of a FODMAP diet in patients with irritable bowel syndrome: focus on small intestinal disaccharidase activity].
    Ter Arkh. 2026;98:99-104.
    PubMed    
    Abstract available
    
    

49. TANG W, Wang J, Wang W, Xue J, et al
    Reviewing the Peripheral and Central Mechanisms of Visceral Hypersensitivity in Intestinal Disorders.
    Int J Med Sci. 2026;23:1121-1143.
    PubMed    
    Abstract available
    
    

50. CHEN L, Yan Y, Shi X, Chen R, et al
    Central amygdala HDAC6 contributes to visceral hypersensitivity and affective comorbidities in IBS-like rats.
    Int Immunopharmacol. 2026;176:116466.
    PubMed    
    Abstract available
    
    

51. HUANG LH, Wang YH, Wu TJ, Lin FY, et al
    Association Between Rheumatoid Arthritis and Gastrointestinal Comorbidities: Evidence From Taiwan's National Health Insurance Database.
    Int J Rheum Dis. 2026;29:e70588.
    PubMed    
    Abstract available
    
    

52. VERAZA DI, Waseem MR, Venezia J, Montero AM, et al
    Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70283.
    PubMed    
    Abstract available
    
    

53. SUJAN AC, Major J, Groenewald CB, Rabbitts JA, et al
    National Medical Expenditures Associated With Pediatric Disorders of Gut-Brain Interaction in the United States.
    Neurogastroenterol Motil. 2026;38:e70279.
    PubMed    
    Abstract available
    
    

54. BAHETI R, Deshkar S, Jadhav S, Mule K, et al
    Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal inflammation.
    Food Res Int. 2026;230:118598.
    PubMed    
    Abstract available
    
    

55. BURNS GL, Roberts F, Wark JA, Fowler S, et al
    Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis.
    EBioMedicine. 2026;126:106198.
    PubMed    
    Abstract available
    
    

56. GARCIA-CEDILLO MF, Huerta-de la Torre MF, Arenas-Martinez JS, Coss-Adame E, et al
    Effects of a Personalised FODMAP Diet Versus the National Institute for Health and Care Excellence (NICE) Dietary Advice on Symptom Control in Patients With Irritable Bowel Syndrome: Randomised Clinical Trial.
    Aliment Pharmacol Ther. 2026 Mar 5. doi: 10.1111/apt.70601.
    PubMed    
    Abstract available
    
    

57. BYALE A, Palsson OS, Simren M, Tack J, et al
    Bloating and Distention Patients Form 6 Distinct Latent Clusters Based on Symptoms, Diet, Psychosocial, and Quality-of-Life Parameters.
    Am J Gastroenterol. 2026;121:754-766.
    PubMed    
    Abstract available
    
    

58. FERREIRA AI, Arieira C, Campelo P, Xavier S, et al
    Three is not a crowd: improving the study of chronic constipation.
    Eur J Gastroenterol Hepatol. 2026 Feb 23. doi: 10.1097/MEG.0000000000003164.
    PubMed    
    Abstract available
    
    

59. BARAZANJI N, Sjodahl J, Orell G, Evripidou M, et al
    From Gut Feeling to Gray Matter: Mapping Defecation Urgency in Irritable Bowel Syndrome.
    Gastroenterology. 2026 Feb 26:S0016-5085(26)00103.
    PubMed    
    Abstract available
    
    

60. LI X
    Reconsidering Bloating as a Core Endpoint in IBS-C: Commentary on Brenner et al. (2025).
    J Gastroenterol Hepatol. 2026 Feb 26. doi: 10.1111/jgh.70320.
    PubMed    
    
    
    

61. TANG ASP, Quek J, Sulaimi F, Sim B, et al
    Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis With Trial Sequential Analysis.
    J Gastroenterol Hepatol. 2026 Mar 12. doi: 10.1111/jgh.70322.
    PubMed    
    Abstract available
    
    

62. QUATRALE G, Chirico N, Colecchia L, Stella G, et al
    Prevalence of disorders of gut-brain-interaction in pediatric patients with in-remission inflammatory bowel disease: An Italian multicenter study.
    J Pediatr Gastroenterol Nutr. 2026 Feb 23. doi: 10.1002/jpn3.70386.
    PubMed    
    Abstract available
    
    

63. TATTAN M, Hanssen DJC, Rosmalen JGM
    Who receives a diagnostic label for fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome? A study in the lifelines cohort.
    J Psychosom Res. 2026;205:112609.
    PubMed    
    Abstract available
    
    

64. SINGH P, Lee A, Sheth NM, Chey WD, et al
    Chronic, Noninfectious Diarrhea: A Review.
    JAMA. 2026 Mar 2. doi: 10.1001/jama.2026.0872.
    PubMed    
    Abstract available